[ Citizens United for Research in Epilepsy – Taking Flight Award | Research Funding ]
Event details
| Date | 11.01.2021 |
| Category | Call for proposal |
Aim: CURE funds research that has the potential to truly transform and save lives. This award seeks to promote the careers of young investigators to allow them to develop a research focus independent of their mentor(s). Researchers may propose basic or clinical studies, but this award mechanism is not intended to support clinical trials. Research that involves collaboration and a multidisciplinary approach is desirable. Applicants will be required to discuss how this avenue of research is independent from their mentor’s research and will lead them to a path of independent epilepsy research. We encourage studies that will provide new directions for epilepsy therapy, prevention and, ultimately, a cure and that will allow applicants to collect the data necessary to support grant application to the National Institutes of Health or similar granting agency.
The following priority areas reflect CURE Epilepsy’s focus on advances that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with our mission.
Funding: max. $100,000
Duration: 1 year
Eligibility: Applicants must generally fall into one of the following categories to be eligible for the Taking Flight Award:
How to Apply: All applicants must submit a Letter of Intent (LOI). The LOI should include a scientific summary and sections on future directions and award relevance, as indicated in the RFA. LOIs and full proposals (by invitation) must be submitted through proposalCENTRAL. To begin an application, applicants will need to create a professional profile, if one does not already exist. If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. After the LOI has been evaluated, selected applicants will be invited to submit a full proposal. At this stage, a signature from an institutional representative will be required; for this, please contact the Research Office.
Deadline, Letter of Intent: 11-January-2021 (9:00 PM ET)
Further information
The following priority areas reflect CURE Epilepsy’s focus on advances that have the potential to truly transform and save lives. Prevention, disease modification and elimination are critical goals and consistent with our mission.
- Transformative research to enhance our understanding of the cellular, molecular, genetic and systems-level mechanisms that lead to any of the epilepsies, facilitating the continued investigation of disease-modifying or preventative strategies
- Innovative approaches that can prevent, modify and/or arrest the development of acquired epilepsy. Examples include epilepsy that develops after stroke, tumor, traumatic brain injury or infection, including febrile infection-related epilepsy syndrome (FIRES) as well new-onset refractory status-epilepticus (NORSE)
- Research that will inform the development of novel therapies to prevent onset or halt the progression of the severe pediatric epilepsies
- Research focused on new, effective treatments for the >30% of the epilepsy population who are pharmacoresistant
- Novel research that furthers our understanding of the causes and ultimate elimination of SUDEP
- Translational, clinical, and clinically informed basic research that will facilitate understanding of the cellular-, molecular-, and systems-level mechanisms that underlie the relationships between sleep and epilepsy
Funding: max. $100,000
Duration: 1 year
Eligibility: Applicants must generally fall into one of the following categories to be eligible for the Taking Flight Award:
- A senior postdoctoral fellow who has a minimum of 3 years postdoctoral experience.
- A researcher with an appointment as an Instructor or Research Assistant Professor who has yet to obtain significant funding (e.g., RO1 grant or equivalent) and has an on-site mentor committed to advising the applicant.
- A faculty member at the assistant professor level who is within one year of having been appointed.
- A clinical fellow who is pursuing a residency in the following areas: neurology, neurosurgery or neurocritical care, and considering an epilepsy focused fellowship.
- Researchers who have already received significant funding (e.g., NIH K99 award or equivalent) are not eligible for CURE Epilepsy funding.
How to Apply: All applicants must submit a Letter of Intent (LOI). The LOI should include a scientific summary and sections on future directions and award relevance, as indicated in the RFA. LOIs and full proposals (by invitation) must be submitted through proposalCENTRAL. To begin an application, applicants will need to create a professional profile, if one does not already exist. If EPFL will serve as your host institution, please use the following institution name in proposalCENTRAL: Ecole Polytechnique Fédérale de Lausanne EPFL. After the LOI has been evaluated, selected applicants will be invited to submit a full proposal. At this stage, a signature from an institutional representative will be required; for this, please contact the Research Office.
Deadline, Letter of Intent: 11-January-2021 (9:00 PM ET)
Further information
- More information about the program is available here
- The Request for Applications (RFA) can be found here
- The application portal can be found here
- For any other questions, please contact the Research Office
Practical information
- General public
- Free